Bioelectronics Corp (BIEL)

[Simpsonly]

my earlier slightly altered
stock, you're a smart guy and I've said so before. Although the lack of BIEL traction is upsetting, the reality is BIEL is operating as a start-up looking for regulatory approval, that is being delayed incredibly by the FDA and probably its own ineptitudes in the application process learning curve and operating on shoe strings. As a result, BIEL is still in business and operating at a burn rate of between $85K and $100K a month if one considers SP in the $ .0015 range, less commissions and fee grabbers.

My initial take is that is not out of this world crazy, considering the potentials and shareholder upside. The higher the price the less the need to dilute shares. If I were CEO, I would look to the folks managing the dilution / selling of those shares to see if the price could be permitted to float higher, especially given the increased demand for stock, thereby giving the company more survival financing and less dilution.